About GSK plc (GSK)
GSK plc is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in London, United Kingdom. GSK has been publicly traded since 1988, giving it 38+ years of trading history.
GSK plc (GSK) has been publicly traded since 1988, making it a 38-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in London, United Kingdom and employs approximately 66,841 people. With a market capitalization of £81 billion, GSK is a large established company.
GSK trades on the London Stock Exchange and is classified as a large-cap-cap stock with a market capitalization of approximately £81 billion. The company employs approximately 66,841 people worldwide.
Key Statistics
- Current Price
- £2,031.00
- Market Cap
- £81.38B
- 52-Week High
- £2,282.00
- 52-Week Low
- £1,242.50
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
GSK Investment Performance
GSK has gained 11.3% year-to-date in 2026. Over the past 5 years, a £1,000 investment in GSK would have grown to £1,570, representing a 57.0% total return. Since its IPO in 1988, a £1,000 investment would now be worth £8,268.
£1,000 Invested in GSK plc (GSK)
How much would £1,000 invested in GSK be worth today?
What would £1,000 invested in GSK 1 year ago be worth today?
A £1,000 investment in GSK plc (GSK) in 2025 would be worth £1,323 as of March 2026, representing a +32.3% total return.
What would £1,000 invested in GSK 3 years ago be worth today?
A £1,000 investment in GSK plc (GSK) in 2023 would be worth £1,452 as of March 2026, representing a +45.2% total return.
What would £1,000 invested in GSK 5 years ago be worth today?
A £1,000 investment in GSK plc (GSK) in 2021 would be worth £1,570 as of March 2026, representing a +57.0% total return.
What would £1,000 invested in GSK 10 years ago be worth today?
A £1,000 investment in GSK plc (GSK) in 2016 would be worth £1,452 as of March 2026, representing a +45.2% total return.
What would £1,000 invested in GSK at IPO be worth today?
A £1,000 investment in GSK plc (GSK) at IPO would be worth £8,268 as of March 2026, representing a +726.8% total return.
Monthly Returns Heatmap
Over the past 37+ years (452 months), GSK plc (GSK) has averaged a monthly return of +0.64% with a median return of +0.63%. The stock had 251 positive months (56%) and 201 negative months (44%). The best month in GSK's history was March 2000 with a +18.3% return, while the worst was August 2022 at -20.1%. Historically, April tends to be the strongest month (averaging +2.2%), and January the weakest (-0.8%).
GSK's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 1991 with a cumulative return of +73.6%, and the worst was 2002 at -34.5%.
Annual Returns
Over 38 years of trading history, GSK plc (GSK) has delivered an average annual return of +7.92% with a median return of +1.85%. The compound annual growth rate (CAGR) is +5.51%. The stock posted gains in 21 years (55%) and losses in 17 years (45%).
GSK's best year was 1991 with a +101.18% gain, while the worst was 2002 at -30.80%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. GSK achieved double-digit gains (10%+) in 14 years. It suffered double-digit losses in 6 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +11.33% | £1,824.36 | £2,031.00 |
| 2025 | +35.56% | £1,345.82 | £1,824.36 |
| 2024 | -7.12% | £1,448.91 | £1,345.82 |
| 2023 | +0.92% | £1,435.76 | £1,448.91 |
| 2022 | -11.13% | £1,615.55 | £1,435.76 |
| 2021 | +19.80% | £1,348.53 | £1,615.55 |
| 2020 | -24.52% | £1,786.56 | £1,348.53 |
| 2019 | +19.37% | £1,496.62 | £1,786.56 |
| 2018 | +12.83% | £1,326.41 | £1,496.62 |
| 2017 | -15.28% | £1,565.61 | £1,326.41 |
| 2016 | +13.86% | £1,375.04 | £1,565.61 |
| 2015 | -0.15% | £1,377.10 | £1,375.04 |
| 2014 | -14.56% | £1,611.76 | £1,377.10 |
| 2013 | +20.78% | £1,334.42 | £1,611.76 |
| 2012 | -9.21% | £1,469.87 | £1,334.42 |
| 2011 | +18.75% | £1,237.82 | £1,469.87 |
| 2010 | -5.96% | £1,316.32 | £1,237.82 |
| 2009 | +2.79% | £1,280.59 | £1,316.32 |
| 2008 | +0.49% | £1,274.34 | £1,280.59 |
| 2007 | -4.79% | £1,338.47 | £1,274.34 |
| 2006 | -8.47% | £1,462.37 | £1,338.47 |
| 2005 | +20.26% | £1,216.01 | £1,462.37 |
| 2004 | -4.49% | £1,273.12 | £1,216.01 |
| 2003 | +7.43% | £1,185.11 | £1,273.12 |
| 2002 | -30.80% | £1,712.47 | £1,185.11 |
| 2001 | -8.82% | £1,878.12 | £1,712.47 |
| 2000 | +8.05% | £1,738.27 | £1,878.12 |
| 1999 | -15.36% | £2,053.62 | £1,738.27 |
| 1998 | +43.65% | £1,429.63 | £2,053.62 |
| 1997 | +51.95% | £940.84 | £1,429.63 |
| 1996 | +3.65% | £907.70 | £940.84 |
| 1995 | +38.29% | £656.38 | £907.70 |
| 1994 | -8.64% | £718.45 | £656.38 |
| 1993 | -8.54% | £785.51 | £718.45 |
| 1992 | -7.03% | £844.95 | £785.51 |
| 1991 | +101.18% | £420.00 | £844.95 |
| 1990 | +8.03% | £388.79 | £420.00 |
| 1989 | +47.00% | £264.48 | £388.79 |
GSK Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating GSK plc as an investment
Valuation
GSK currently trades at a trailing P/E ratio of 14.6, which is considered low relative to the broader market. The forward P/E of 10.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 497.7. The price-to-sales ratio is 2.5.
Dividends
GSK plc pays a dividend to shareholders with a current yield of 3.55%. This translates to £0.72 per share annually. The payout ratio of 46% indicates sustainable dividend coverage.
Risk & Volatility
GSK has a beta of 0.32, indicating it is less volatile than the overall market. The stock's 52-week range is £1242.50 to £2282.00, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 20 analyst opinions, GSK has a consensus "hold" rating. The average price target of £2032.25 suggests 0.1% upside from current levels.
Frequently Asked Questions: GSK
What sector is GSK in? ▼
GSK operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has GSK performed historically? ▼
Over 38 years of trading history, GSK has posted gains in 21 years (55% of the time). The best year was 1991 with a +101.2% return. Past performance does not guarantee future results.
How can I invest in GSK? ▼
You can invest in GSK through any brokerage account that offers access to the London Stock Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold GSK.
Does GSK pay dividends? ▼
GSK plc pays a dividend to shareholders with a current yield of 3.55%. This translates to £0.72 per share annually. The payout ratio of 46% indicates sustainable dividend coverage.
What does GSK plc do? ▼
GSK plc is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in London, United Kingdom.
What sector is GSK in? ▼
GSK operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
When did GSK go public? ▼
GSK plc went public in 1988, making it a 38-year-old public company as of 2026.
How much would £1,000 invested in GSK 5 years ago be worth today? ▼
A £1,000 investment in GSK five years ago would be worth approximately £1,570 today, representing a 57.0% return.
Does GSK pay dividends? ▼
Yes, GSK plc pays a dividend with a current yield of 3.55%, which is £0.72 per share annually.
What is GSK's market cap? ▼
GSK plc has a market capitalization of £81 billion, classifying it as a large-cap company.
What is GSK's P/E ratio? ▼
GSK has a trailing P/E ratio of 14.6 and a forward P/E of 10.3, which measures how much investors are paying per dollar of earnings.
Is GSK a buy, hold, or sell? ▼
Based on 20 opinions, GSK has a consensus "hold" rating. The average price target is £2032.25.
Last updated: 3/14/2026